Laboratorios Farmaceuticos Financials
| LABFF Stock | USD 90.61 0.00 0.00% |
Laboratorios |
Laboratorios Farmaceuticos Stock Summary
Laboratorios Farmaceuticos competes with ALK Abell, Genscript Biotech, Shanghai Junshi, Camurus AB, and InnoCare Pharma. Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. Laboratorios Farmaceticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L. Laboratorios Farmaceuticos operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1852 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Calle Jos Isbert, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.rovi.es |
| Phone | 34 91 021 30 00 |
| Currency | USD - US Dollar |
Laboratorios Farmaceuticos Key Financial Ratios
There are many critical financial ratios that Laboratorios Farmaceuticos' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Laboratorios Farmaceuticos reports annually and quarterly.| Return On Equity | 0.39 | |||
| Return On Asset | 0.18 | |||
| Beta | 0.47 | |||
| Z Score | 29.4 |
Laboratorios Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Laboratorios Farmaceuticos's current stock value. Our valuation model uses many indicators to compare Laboratorios Farmaceuticos value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Laboratorios Farmaceuticos competition to find correlations between indicators driving Laboratorios Farmaceuticos's intrinsic value. More Info.Laboratorios Farmaceuticos Rovi is rated second overall in return on equity category among its peers. It also is rated second overall in return on asset category among its peers reporting about 0.47 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Laboratorios Farmaceuticos Rovi is roughly 2.13 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Laboratorios Farmaceuticos' earnings, one of the primary drivers of an investment's value.Laboratorios Farmaceuticos Systematic Risk
Laboratorios Farmaceuticos' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Laboratorios Farmaceuticos volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on Laboratorios Farmaceuticos correlated with the market. If Beta is less than 0 Laboratorios Farmaceuticos generally moves in the opposite direction as compared to the market. If Laboratorios Farmaceuticos Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Laboratorios Farmaceuticos is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Laboratorios Farmaceuticos is generally in the same direction as the market. If Beta > 1 Laboratorios Farmaceuticos moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Laboratorios Pink Sheet analysis
When running Laboratorios Farmaceuticos' price analysis, check to measure Laboratorios Farmaceuticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorios Farmaceuticos is operating at the current time. Most of Laboratorios Farmaceuticos' value examination focuses on studying past and present price action to predict the probability of Laboratorios Farmaceuticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorios Farmaceuticos' price. Additionally, you may evaluate how the addition of Laboratorios Farmaceuticos to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |